A skin treatment device for locally treating skin with light is provided that comprises a tip, a light emission element, a safety mechanism comprising an optical element and an optical element positioning structure. The optical element receives a converging light beam from the light emission element. The optical element is configured to operate as a diverging lens. The optical element positioning structure positions the optical element in a safety position, or in a treatment position when the tip is in contact with the skin to be treated, and allows movement of the optical element between both positions. In the safety position, the optical element is arranged at a position on the optical axis to generate an eye-safe light beam. In the treatment position, the optical element is arranged at another position on the optical axis to generate a treatment light beam.
|
1. A skin treatment device for locally treating skin with light, the skin treatment device comprising:
a tip arranged and configured to be brought into contact with the skin;
a light source arranged and configured to emit, in use, a light beam towards the tip along an optical axis, the light beam being a converging light beam, the optical axis extending in a longitudinal direction of the skin treatment device through the tip; and
a diverging lens provided proximate to the tip in the light beam, wherein the diverging lens has on a first side, a light exit surface facing the tip and, on a second side opposite the first side, a light entrance surface facing the light source to receive the light beam; and
wherein the diverging lens is movable via the tip along the optical axis between a treatment position when the tip is in contact with the skin and a safety position when the tip is not in contact with the skin,
wherein, in the safety position, the light entrance surface of the diverging lens is arranged in the light beam at a first position on the optical axis to obtain an eye-safe light beam at the light exit surface, and
wherein, in the treatment position, the light entrance surface of the diverging lens is arranged in the light beam at a second position on the optical axis at a distance proximal or distal from the first position to obtain a treatment light beam at the light exit surface.
2. The skin treatment device according to
3. The skin treatment device according to
4. The skin treatment device according to
a housing including a front wall being arranged proximate to a skin contact surface of the tip for defining the safety position by limiting movement of the diverging lens in the first direction, the front wall including an opening for allowing the diverging lens to partially protrude from the housing if the diverging lens is arranged at the safety position; and
a movement limiting wall arranged at a distance from the skin contact surface of the tip for defining the treatment position by limiting movement of the diverging lens in the second direction when the diverging lens is pressed to the skin.
5. The skin treatment device according to
6. The skin treatment device according to
wherein the light exit surface of the diverging lens has a round shape.
7. The skin treatment device according 1,
wherein the light entrance surface of the diverging lens is a round shaped recess having a first radius (Ri), and
wherein the light exit surface of the diverging lens has is a round shaped surface having a second radius (Ro), the second radius (Ro) being at least three times larger than the first radius (Ri).
8. The skin treatment device according to
9. The skin treatment device according to
10. The skin treatment device according to
11. The skin treatment device according to
12. The skin treatment device according to
13. The skin treatment device according to
14. The skin treatment device according to
wherein the beam angle of the treatment light beam is smaller than 4°, and
wherein a diameter of the treatment light beam, measured at the light exit surface, is smaller than 1 mm.
15. The skin treatment device according to
16. The skin treatment device according to
17. The skin treatment device according to
18. The skin treatment device according to
19. The skin treatment device according to
20. The skin treatment device according to
|
This application is the U.S. National Phase application under 35 U.S.C. § 371 of International Application No. PCT/EP2015/057187, filed on Apr. 1, 2015, which claims the benefit of International Application No. 14163091.3 filed on Apr. 1, 2014. These applications are hereby incorporated by reference herein.
The invention relates to the field of skin treatment devices and safety solutions for such devices. More in particular, the application relates to the field of precision light-based skin treatment devices in which a relatively narrow beam of light is used to locally treat the skin.
Different types of light-based skin treatment devices are known that can treat different targets within the skin. These light-based devices use low or medium power light sources, like LED's, or relatively high power light sources, like IPL (intense pulsed light) and laser. With the low and medium power light sources certain targets within the skin, like fibroblast cells, can be stimulated to enhance the production of collagen tissue. Relatively high power light sources heat specific targets in the skin, like melanin, blood or water to induce local damages. These light-based skin treatments are dependent on the wavelength absorption profile of the selected target objects in the skin and are known as “selective photothermolysis”. Fractional laser treatment devices have the purpose of non-ablative fractional photothermolysis of the targeted skin tissue, in particular by heating the water in the targeted skin tissue, for example, to thermally denature the collagen tissue in the dermis. In these fractional laser treatments, laser pulses create microscopic treatment zones (MTZs) of thermally denatured skin tissue surrounded by thermally undamaged tissue. This boosts skin repair mechanisms and improves skin appearance. Denatured collagen will be replaced in time, typically between one and three months, by new collagen. This will result in a reduction of wrinkles and fine lines. As an additional benefit the cells in the epidermis are damaged and replaced within several days. This replacement of the epidermal cells will result in a more even skin tone and an overall increase of the radiance or glow of the skin. Furthermore, fractional skin treatment devices are known that are ablative in that they completely remove the tissue in the micro-zones. Currently these ablative devices are less suitable for home-use, but are used in professional environments. Light is not only used to treat skin tissue, but is also used to achieve temporary hair growth reduction. In this application a broadband IPL (intense pulsed light) flash is used to damage the hair follicle and stop or reduce the hair growth. In this application, selective photothermolysis is obtained by matching the IPL wavelength spectrum and the duration of the light flashes to the absorption spectrum and thermal relaxation time of melanin, which is present in a large amount in hair tissue. Furthermore, IPL can be used to reduce the visibility of pigmented spots.
Both above mentioned solutions are based on large aperture devices to efficiently treat relatively large areas of interest. However, there is a growing interest in devices that offer improved precision, for example pen-like devices, by means of which spot treatments are achieved. A pen-like device has often a relatively small tip. It is relatively difficult to design a device with such a small treatment tip that includes safety mechanisms providing a level of safety such that the device is suitable for home-use. The safety mechanism needs to prevent the skin treatment device from emitting a potentially unsafe intense light beam that may harm the human eye. It is common to all electronic devices to include an ON button which should be pressed by the user to enable a certain device component, e.g. turning on a light source. It is desired to have an additional safety mechanism.
Published patent application US2012/0323229 and, for example, also published patent application US2004/0176754 disclose safety means to detect whether a front side, having a light exit window, of a skin treatment device is close to or in contact with the skin. These safety means are, for example, based on a pressure sensor, mechanical switches or a reflectometer contact system or the like. Such safety means are relatively complex, and thus relatively expensive. When such safety means are to be miniaturized, these safety means become even more expensive and sensitive to damages.
It is an object of the invention to provide a better safety mechanism for a skin treatment device.
A first aspect of the invention provides a skin treatment device. Advantageous embodiments are defined in the dependent claims.
A skin treatment device in accordance with the first aspect of the invention comprises a tip, a light emission element and a safety mechanism. The tip is arranged and configured to be brought into contact with the skin. The light emission element is arranged and configured to emit, in use, a light beam towards the tip along an optical axis. The light beam is a converging light beam. The optical axis extends in a longitudinal direction of the skin treatment device through the tip. The safety mechanism is provided proximate to the tip and is arranged to receive the light beam. The safety mechanism comprises an optical element and an optical element positioning structure. The optical element is arranged on the optical axis and is configured to operate as a diverging lens and is arranged to be brought into contact with the skin. The optical element comprises, on a first side, a light exit surface and, on a second side opposite the first side, a light entrance surface for receiving the light beam. The optical element positioning structure is configured and arranged to position the optical element in a safety position or alternatively in a treatment position and to allow the optical element to move from the safety position to the treatment position along the optical axis and vice versa. The optical element positioning structure is configured to position the optical element in the treatment position when the tip is in contact with the skin and to position the optical element in the safety position when the tip is not in contact with the skin. In the safety position the light entrance surface is arranged in the light beam at a first position on the optical axis to obtain an eye-safe light beam at the light exit surface. In the treatment position the light entrance surface is arranged in the light beam at a second position on the optical axis at a distance from the first position to obtain a treatment light beam at the light exit surface.
The treatment light beam has in general a relatively high energy density. The skin treatment device only emits the light beam of the light emission element in the form of the treatment light beam when the tip of the skin treatment device is in contact with the skin that must be treated. Only then the optical element positioning structure moves the optical element into the treatment position. When the tip is not in contact with the skin, the optical element is moved by the optical element positioning structure into the safety position. In the safety position, the optical element refracts the light beam received from the light emission element into an eye-safe light beam. In general, an eye-safe light beam has a relatively low energy density. Thus, at different light emission angles of the light beam, the amount of emitted energy is relatively low. The eye-safe light beam has a lower energy density than the treatment light beam. When, undesirably, the eye-safe light beam is emitted towards an eye of a human (which is only possible when the skin treatment device is not in contact with skin), the light beam is more harmless for the eye than when the treatment beam would be emitted towards the eye. Thus, an optical safety mechanism is provided which reduces the risk of harming the eyes of a user.
Another advantage is that it is relatively easy to miniaturize the safety mechanism because it is not difficult to manufacture a small optical element that is small enough to be used at a tip of a skin treatment device. By virtue thereof, the safety mechanism can be relatively easily integrated into the tip of the skin treatment device. It is further prevented that electronics or electronic connections are required. The skin treatment device is safe by design.
The optical element is configured to operate as a diverging lens, which means that, seen along the optical axis, the optical element as a whole operates as a negative lens. In general, the skilled person would consider using a converging lens when, for example, characteristics of impinging light beams must be changed. The skilled person is biased against the use of negative lenses, because, in general, negative lenses do not provide a lot of flexibility because they are not well suited to focus a light beam to a focal point. As such, it is unexpected that a diverging lens is able to provide an advantageous effect in the skin treatment device. When, for example, the optical element is positioned in or close to the focal point of the light beam, the diverging effect of the optical element is almost cancelled out such that one may still obtain, for example, a sufficiently effective treatment light beam, while, when the optical element is not so close to the focal point of the light beam, the light is strongly diverged for, for example, obtaining the eye-safe light beam.
Optionally, the light beam emitted by the light emission element converges to a focal point on the optical axis. The treatment position is a position wherein the light entrance surface of the optical element is proximate to the focal point to obtain, at the light exit surface of the optical element, a treatment beam that is approximately a parallel light beam. In the treatment position, the light entrance surface may slightly deviate from the focal point to compensate, by means of the diverging character of the optical element, for the converging character of the light beam that is received from the light emission element.
Optionally, the safety position is a position in which the light entrance surface of the optical element is distant from the focal point to obtain, at the light exit surface of the optical element, an eye-safe light beam that diverges.
Optionally, the optical element positioning structure comprises a resilient element for applying a first force to the optical element in a first direction parallel to the optical axis and away from the light emission element towards the safety position. Optionally, the optical element is arranged at the tip to receive a force substantially in a second direction towards the treatment position when the tip is pressed to the skin for moving the optical element towards the treatment position. The second direction is substantially opposite to the first direction. Thus, according to these optional embodiments, the optical element positioning structure only uses mechanical elements for moving the optical element along the optical axis between the treatment position and the safety position, and vice versa. This is relatively fail-safe. By using a resilient element for pressing the optical element towards the safety position, the optical element has the tendency to move to the safety position and, thus, the skin treatment device emits the eye-safe light beam when not being pressed to the skin. Optionally, the resilient element is a spring.
Optionally, the optical element positioning structure comprises a housing comprising a front wall being arranged proximate to a skin contact surface of the tip for defining the safety position by limiting movement of the optical element in the first direction. The front wall comprises an opening for allowing the optical element to partially protrude from the housing if the optical element is arranged at the safety position. The housing further comprises a movement limiting wall arranged at a distance from the skin contact surface of the tip for defining the treatment position by limiting movement of the optical element in the second direction when the optical element is pressed to the skin. Thus, the means which define how far the optical element can move along the optical axis are also constituted by mechanical elements and, consequently, the safety position and the treatment position are well-defined and the safety mechanism is relatively fail-safe.
Optionally, the light entrance surface has a selected shape that acts as a diverging lens. Optionally, the light entrance surface is a surface of a recess on the second side of the optical element. In this embodiment the light entrance surface is a concave surface. On the second side of the optical element, the recess has a circular cross-sectional shape, and the circular cross-sectional shape has a first radius. In the safety position of the optical element, a radius of the light beam, at a position where the light beam impinges on the light entrance surface, is at least 80% of the first radius. Optionally, in the safety position of the optical element, the radius of the light beam, at a position where the light beam impinges on the light entrance surface, is in a range from 80% to 100% of the first radius. The circular cross-sectional shape is arranged symmetrically around the optical axis. When the impinging light beam has a radius that is about equal to the first radius of the circular cross-sectional shape of the recess, which acts as a diverging lens in the safety position of the optical element, the light beam is strongly diverged by the recess. In this optional embodiment, about the whole light beam emitted by the light emission element impinges on the light entrance surface, which prevents unwanted scattering or refracting effects at an edge of the light entrance surface or at locations outside the light entrance surface. When the light entrance surface, acting as a diverging lens, is a recess in the light entrance surface of the optical element, it is relatively easy to manufacture such a diverging lens. Optionally, the recess in the light entrance surface has approximately the shape of a semi-sphere. When the recess in the light entrance surface has such a shape, the diverging effect of the light entrance surface will be relatively large.
Optionally, the light exit surface of the optical element has a protruding, smooth, round shape. In this embodiment the light exit surface is a convex surface. When the light exit surface of the optical element has said protruding, smooth, round shape, the tip of the skin treatment device contacting the skin may be constituted by the light exit surface. Said smooth, round shape is comfortable when the light exit surface is in contact with the skin, and the user may move or glide the tip of the skin treatment device over the skin without causing discomfort. Optionally, the protruding, smooth, round shape is approximately a semi-sphere. This shape is very comfortable when the light exit surface is moved over the skin.
Optionally, in an embodiment wherein the light entrance surface is a spherically shaped recess that has said first radius, and wherein the light exit surface is spherically shaped and has a second radius, the second radius is at least three times larger than the first radius. The light exit surface having a protruding spherical shape acts as a converging lens. The optical element as a whole has a diverging character and, thus, the second radius is larger than the first radius to prevent that the light exit surface cancels out the diverging effect of the light entrance surface. The larger the second radius, compared to the first radius, the larger the diverging effect of the optical element. Optionally, the second radius is at least five times larger than the first radius. Optionally, the second radius is at least eight times larger than the first radius.
Optionally, the optical element is made of a light transmitting material having a refractive index that matches the refractive index of human skin. In particular, the refractive index of the light transmitting material is within a range from 80% to 120% of the refractive index of human skin. When the light exit surface of the optical element is in contact with the skin, the light exit surface refracts the light only to a limited extent as a result of the matched refractive indices. Thus, when the optical element, in the treatment position, is in contact with the skin, it is prevented that the light exit surface of the optical element has a significant influence on the convergence or divergence of the treatment light beam. In other words, when the optical element, in the treatment position, is in contact with the skin, the light entrance surface determines the convergence or divergence of the treatment light beam.
Optionally, the skin treatment device is pen-shaped and is configured to be operated by a hand of a user. Thus, the skin treatment device is relatively small and has a low weight. The fact that the device is pen-shaped provides the user with a better view on and around the area of the skin that is being treated. As a result of the relatively small tip of the device, the skin treatment device can be positioned on the skin with relatively high precision. Other advantages of a pen-shaped skin treatment device include lower production costs, a lower price for consumers, increased treatment efficiency due to improved targeting of the treatment area, improved ergonomics and easier handling.
Optionally, the light emission element comprises a laser for emitting the light beam and a lens for converging the light beam towards a focal point on the optical axis.
Optionally, the eye-safe light beam is a diverging light beam. In the case of a diverging light beam, the cross-sectional shape of the light beam becomes larger with an increasing distance from the skin treatment device. Thus, the eye-safety increases when the user increases the distance between his eyes and the skin treatment device, because the light energy is distributed along a larger cross-sectional area. Furthermore, in comparison with a parallel light beam, a diverging light beam has less energy per light emission angle. Optionally, a beam angle of the eye-safe light beam is larger than a beam angle of the light beam received by the optical element. Optionally, the beam angle of the eye-safe light beam is larger than 20°. Optionally, the beam angle of the eye-safe light beam is larger than 28°. Such relatively large beam angles provide a relatively widely diverging eye-safe light beam and, thus, the risk of harming eyes of a person is relatively low when the skin treatment device emits the eye-safe light beam. A beam angle is defined as the angle between light rays on opposite sides of the optical axis of the light beam, wherein said light rays have an intensity value that is half the maximum intensity value of a (central) light ray of the light beam.
Optionally, the treatment light beam is a substantially parallel light beam. It is to be noted that it is practically impossible to generate, when using laser light, an exactly parallel light beam. Therefore, in an optional embodiment, ‘substantially parallel’ means that a beam angle of the treatment light beam is smaller than 4°. Optionally, the beam angle of the treatment light beam is smaller than 2°. Optionally, a diameter of the treatment light beam, measured at the light exit surface, is smaller than 1 mm. Such treatment light beams are sufficiently effective to locally treat the skin with high precision, and all the energy emitted by the light emission element is concentrated in a relative narrow light beam to ensure effective treatment.
These and other aspects of the invention are apparent from and will be elucidated with reference to the embodiments described hereinafter.
It will be appreciated by those skilled in the art that two or more of the above-mentioned options, implementations and/or aspects of the invention may be combined in any way deemed useful.
Modifications and variations of the device can be carried out by a person skilled in the art on the basis of the present description.
In the drawings:
It should be noted that items denoted by the same reference numerals in different Figures have the same structural features and the same functions. Where the function and/or structure of such an item have been explained, there is no necessity for repeated explanation thereof in the detailed description.
The Figures are purely diagrammatic and not drawn to scale. Particularly for clarity, some dimensions are exaggerated strongly.
The skin treatment device 100 comprises a battery 102, an electronic circuitry 104 for controlling operation of the skin treatment device 100 and/or driving a light source 106 (optionally a laser diode), which light source 106 is capable of generating a light beam, a focusing lens 108 which focuses the light beam generated by the light source 106 to a converging light beam 120 towards a focal point, a control switch 110, a tip 128 which comprises a safety mechanism comprising an optical element 124 and an optical element positioning structure 122. The light source 106, the focusing lens 108 and the optical element are arranged around an optical axis 126 that extends in the longitudinal direction of the skin treatment device 100. The light source 106 and the focusing lens 108 together form a light emission element of the skin treatment device 100 for generating the converging light beam 120. Embodiments of the skin treatment device are not limited to light emission elements as discussed above; other suitable light emission elements that generate converging light beam 120 may be used as well. Embodiments of the skin treatment device are not limited to pen-shaped skin treatment devices. However, the pen-shape provides specific advantages as discussed in this document.
A user may operate the control switch 110 to instruct the skin treatment device 100 to generate a light beam for treating the skin. The electronic circuitry 104 receives a signal from the control switch 110 and, subsequently, the electronic circuitry 104 may decide to drive the light source 106 such that a beam of light is generated. The light source 106 emits the beam of light towards the focusing lens 108 which transmits the converging light beam 120 towards the tip 128 of the skin treatment device 100. The converging light beam 120 has a focal point (not shown in
It is to be noted that eye safety does not only depend on the amount of light energy per light emission angle. In particular, when the light emission element uses a diode laser to generate the light, the wavelength and the pulse length are also important parameters that influence the eye safety of the eye-safe light beam. IEC-60825-1 and ANSI Z136.1 standards disclose methods of calculating maximum permissible exposure values. This document mainly focuses on a mechanism to influence the amount of light energy per light emission angle to obtain the treatment beam and to obtain the eye-safe light beam.
In the example of
In the treatment position, the spherical recess in the rear side of the optical element is proximate to the focal point of the converging light beam 120. At this point the strongly divergent character of the spherical recess is cancelled out, or is used to a limited extend to compensate for the converging character of the converging light beam 120. As a result, a relatively narrow treatment light beam 270 is formed which has a relatively high energy density. The treatment light beam 270 comprises, for example, substantially parallel oriented light rays within a beam that has a radius that is smaller than, for example, 1 mm. It might also be that the treatment light beam 270 has a slightly diverging character, but then the beam angle of the treatment light beam should be small, for example, not larger than 4° or, in another example, not larger than 2°.
In
The above discussed safety mechanism 300 is completely based on mechanical and optical elements. In general, such systems are fail-safe because they do not depend on electronic circuitry or specific actuators that must, for example, be activated by means of power. However, embodiments of safety mechanism 300 are not limited to the use of optical and mechanical elements only. Instead of the springs 323, one or more actuators may be used that are controlled by a circuitry in such a way that the actuators provide a force to the optical element 224 that moves the optical element 224 towards the safety position 352 when the tip of the skin treatment device is not in contact with the skin.
Optical element 400 comprises a light entrance surface that is round and that is formed by a recess 402 in a light transmitting material. As a result, the light entrance surface 404 forms a diverging lens. The recess 402 has a radius Ri. The light exit surface 406 is a flat surface which has no lens function. When the light entrance surface 404 is arranged at a focal point of the impinging light beam, the diverging character of the light entrance surface 404 is cancelled and, thus, a position of the light entrance surface 404 proximate to the focal point is an advantageous position for obtaining a relatively narrow treatment light beam. When the light entrance surface 404 is arranged distant from the focal point of the impinging light beam, and when the radius of the impinging light beam at the position where it impinges on the light entrance surface 404 is only marginally smaller than the radius Ri of the recess 402, the diverging character of the light entrance surface is used to a maximum extent and the impinging light beam is strongly diverged. Thus, in the safety position, the radius of the impinging light beam (as received from the light emission element) is about equal to the radius Ri of the recess 402 and is at least not larger than the radius Ri of the recess 402 because that would result in undesired scattering effects.
The light entrance surface 434 of the optical element 430 is also a round recess 432 in a light transmitting material that acts as a relatively strong diverging lens. The round recess 432 is made in a part that protrudes from the main body of the optical element. The light exit surface 436 is a smooth round surface which acts as a converging lens. The radius Ri of the recess 432 is at least several times smaller than the radius Ro of the round light exit surface 436, for example, at least 3 times smaller, or at least 5 times smaller. As a result, the converging character of the light exit surface 436 is smaller than the diverging character of the light entrance surface 434 and the optical element 430 as a whole acts as a diverging lens. The smooth, round light exit surface 436 has a shape that is comfortable for contacting the skin to be treated and for moving over the skin to be treated.
Optical element 460 is similar to optical element 430, however, the round recess 462 is not provided in an element that protrudes from the main body of the optical element, but is directly provided in the main body of the optical element and, therefore, optical element 460 may be cheaper because of manufacturing benefits.
A specific embodiment of a shape of the light entrance surface 404, 434, 464 is a shape that corresponds to a portion of a sphere, for example, a semi-sphere. A specific embodiment of a shape of the light exit surface 436 is a shape that corresponds to a portion of a sphere, for example, a semi-sphere.
Simulation result 504 of
The indicated distance 504 is the distance over which the optical element 430 moves along the optical axis from the treatment position 250 to the safety position 252, and vice versa.
In an embodiment, the light entrance surface 434 and the light exit surface 436 have the shape of a semi-sphere. The light entrance surface 434 forms a lens that has a focal distance of −0.2 mm, and that has a 0.2 mm lens radius. The light exit surface 436 forms a lens that has a focal distance of 2 mm and that has a 2 mm lens radius. The lens 552 has, for example, a lens diameter of 2 mm and a focal distance of 30 mm and then the first beam angle θ1 is about 8°. The light entrance surface 434 is arranged at a position where the light beam is diverging and has a radius of about 2 mm. Then the second beam angle θ2 is about 30°. When the optical element 430 is in its treatment position, the second beam angle θ2 is smaller than 4° or, optionally, smaller than 2° or, optionally, smaller than 1°. Optionally, when the optical element 430 is in its treatment position, the light rays of the treatment light beam are arranged substantially in parallel.
In summary, the application provides a skin treatment device for locally treating skin with light. The skin treatment device comprises a tip, a light emission element, a safety mechanism comprising an optical element and an optical element positioning structure. The optical element receives a converging light beam from the light mission element. The optical element is configured to operate as a diverging lens. The optical element positioning structure positions the optical element in a safety position or in a treatment position when the tip is in contact with the skin to be treated and allows movement between both positions. In the safety position, the optical element is arranged at a position on the optical axis to generate an eye-safe light beam. In the treatment position, the optical element is arranged at another position on the optical axis to generate a treatment light beam.
It should be noted that the above-mentioned embodiments illustrate rather than limit the invention, and that those skilled in the art will be able to design many alternative embodiments without departing from the scope of the appended claims.
In the claims, any reference signs placed between parentheses shall not be construed as limiting the claim. Use of the verb “comprise” and its conjugations does not exclude the presence of elements or steps other than those stated in a claim. The article “a” or “an” preceding an element does not exclude the presence of a plurality of such elements. The invention may be implemented by means of hardware comprising several distinct elements. In the device claim enumerating several means, several of these means may be embodied by one and the same item of hardware. The mere fact that certain measures are recited in mutually different dependent claims does not indicate that a combination of these measures cannot be used to advantage.
Palero, Jonathan Alambra, Jurna, Martin
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
6050990, | Dec 05 1996 | ThermoLase Corporation | Methods and devices for inhibiting hair growth and related skin treatments |
7160287, | Aug 23 2001 | Jerry, Siegel | Apparatus and method for performing radiation energy treatments |
7184614, | Jul 07 2003 | Candela Corporation | Method and apparatus for improving safety during exposure to a monochromatic light source |
9283037, | Apr 18 2006 | Pantec Biosolutions AG | Laser microporator |
20040176754, | |||
20070083190, | |||
20080027518, | |||
20080140164, | |||
20110040358, | |||
20120323229, | |||
20130317571, | |||
JP8243181, | |||
WO2008008971, | |||
WO2010045973, | |||
WO2012106678, | |||
WO3049633, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Apr 01 2015 | Koninklijke Philips N.V. | (assignment on the face of the patent) | / | |||
Apr 01 2015 | JURNA, MARTIN | KONINKLIJKE PHILIPS N V | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 039872 | /0839 | |
Apr 03 2015 | PALERO, JONATHAN ALAMBRA | KONINKLIJKE PHILIPS N V | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 039872 | /0839 |
Date | Maintenance Fee Events |
Jun 20 2023 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Date | Maintenance Schedule |
Dec 31 2022 | 4 years fee payment window open |
Jul 01 2023 | 6 months grace period start (w surcharge) |
Dec 31 2023 | patent expiry (for year 4) |
Dec 31 2025 | 2 years to revive unintentionally abandoned end. (for year 4) |
Dec 31 2026 | 8 years fee payment window open |
Jul 01 2027 | 6 months grace period start (w surcharge) |
Dec 31 2027 | patent expiry (for year 8) |
Dec 31 2029 | 2 years to revive unintentionally abandoned end. (for year 8) |
Dec 31 2030 | 12 years fee payment window open |
Jul 01 2031 | 6 months grace period start (w surcharge) |
Dec 31 2031 | patent expiry (for year 12) |
Dec 31 2033 | 2 years to revive unintentionally abandoned end. (for year 12) |